The standard treatment for urinary tract infections is a short course of antibiotics (NHS guidance), however, there are other research based treatments that can be effective. Effective non-antibiotic treatments 1.Creams/tablets: For post menopausal women, who have not had a period for a year, o...
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills. In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from ...
Dental health (NHS inform)– Advice and guidance relating to all aspects of oral health from brushing to nutrition for all ages. Disability Rights UK Get Yourself Active– Free classes and exercises for people living with a disability.
Despite official guidance intended to eliminate mixed sex wards, none of the NHS trusts in England require a patient to have begun transition for them to be treated as their preferred sex, according to responses to more than 100 Freedom of Information request...
Ms Evans also pointed out that a lot of children have already been referred to adult services prior to turning 18 years of age, so adult gender identity services will also need to conduct a review of relevant patients. “If a parent questioned consent, there could also be reforms there.”...
The role of chief executive in the NHS in England was first created in 1985 and it is the first time that a woman has been given the title. Ms Pritchard will be in charge of the NHS's annual budget of almost £150 billion and the service's 1.2 million staff. ...
Final guidancesaid that approval was conditional on the manufacturer supplying brigatinib at an agreed price discount. Paula Chadwick, chief executive of the Roy Castle Lung Cancer Foundation, commented: "The approval of brigatinib by NICE adds another option for patients with this particular type...
Abemaciclib(Vernezios, Eli Lilly) was accepted for the treatment of advanced or metastatic breast cancer in two different settings. The SMC said it was accepted for use in combination with aromatase inhibitors as an initial therapy in patients who have not had previous endocrine-based therapy. ...